Product Images Lapatinib
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Lapatinib NDC 0480-3237 by Teva Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
chemical structure - image 1
Figure 1 - image 2
This text appears to show a chart or table displaying the dosages of Capecitabine and Lapatinib over time in weeks, possibly in relation to progression-free survival. It indicates the dosage values and a time scale up to 100 weeks.*
Figure 2 - image 3
This text mentions the cumulative progression-free data for different treatments involving Capecitabine and Lapatinib over time (in weeks). The dosages of Capecitabine and Lapatinib used in the treatments are also provided.*
Figure 3 - image 4
This text appears to be a table showing the cumulative progression-free time data for two different treatment regimens involving Letrozole. One regimen involves just Letrozole (2.5 mg), while the other combines Lapatinib (1,500 mg) with Letrozole (2.5 mg). The graph shows time in weeks along the x-axis from 80 to 220 weeks. Unfortunately, no specific data points or results are provided.*
Figure 4 - image 5
This text appears to be a schedule or chart showing different combinations of medications administered at various time intervals. It includes Trastuzumab, Lapatinib at different doses, and combination therapies over a period of 45 months.*
Label 250 mg, 150 Tablets - image 6
This text provides information about a medication with the NDC code 0480-3237-51. Each tablet contains 398 mg of lapatinib ditosylate, equivalent to 250 g of lapatinib. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C. The medication is manufactured for Teva Pharmaceuticals and comes in a bottle containing 150 tablets. Serialization coding area is also mentioned. It is advised to keep the medication out of reach of children and to use safety closures.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
